[Osteoporosis in men]

Dtsch Med Wochenschr. 2003 Apr 25;128(17):925-8. doi: 10.1055/s-2003-38842.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Alendronate / therapeutic use
  • Androgens / therapeutic use
  • Calcium Channel Blockers / therapeutic use
  • Diagnosis, Differential
  • Etidronic Acid / analogs & derivatives*
  • Etidronic Acid / therapeutic use
  • Fractures, Bone / etiology
  • Humans
  • Hydroxycholecalciferols / therapeutic use
  • Hypogonadism / complications
  • Hypogonadism / drug therapy
  • Male
  • Osteoporosis / complications
  • Osteoporosis / diagnosis*
  • Osteoporosis / therapy*
  • Primary Prevention
  • Risedronic Acid
  • Risk Factors

Substances

  • Androgens
  • Calcium Channel Blockers
  • Hydroxycholecalciferols
  • Risedronic Acid
  • Etidronic Acid
  • alfacalcidol
  • Alendronate